Expression of hyaluronan in benign and malignant breast lesions

被引:0
|
作者
Auvinen, PK
Parkkinen, JJ
Johansson, RT
Agren, UM
Tammi, RH
Eskelinen, MJ
Kosma, VM
机构
[1] KUOPIO UNIV HOSP, DEPT PATHOL, SF-70210 KUOPIO, FINLAND
[2] UNIV KUOPIO, DEPT PATHOL & FORENS MED, FIN-70211 KUOPIO, FINLAND
[3] UNIV KUOPIO, DEPT ANAT, FIN-70211 KUOPIO, FINLAND
[4] KUOPIO UNIV HOSP, DEPT SURG, SF-70210 KUOPIO, FINLAND
关键词
D O I
10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.0.CO;2-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hyaluronan (HA) is one of the extracellular-matrix components involved in wound healing, tumour growth and metastasis, Due to the limited data on HA expression in benign and malignant breast lesions, we analyzed its presence in these lesions by using the biotinylated-hyaluronan-binding region and the link-protein complex (bHABC) of cartilage proteoglycan as a specific probe. In all benign breast lesions, the expression of HA was restricted to the stromal connective tissue, the ductal epithelial cells being completely devoid of HA. In malignant breast tumours, the intensity of stromal HA staining was significantly stronger than in benign lesions. In addition, HA was detected on cell membranes or in cytoplasms of adenocarcinoma cells, in some cases of ductal carcinoma in situ and in 31% of malignant tumours, The staining pattern was mostly similar in all breast-cancer types studied, i.e., ductal, lobular, tubular, mucinous and medullary, In ductal breast cancer, intense HA expression in stroma and carcinoma cells correlated statistically significantly to poor differentation of carcinoma, suggesting that altered HA expression may affect the mechanisms of breast-cancer progression. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 50 条
  • [31] YKL-40 expression in benign and malignant lesions of the breast: A methodologic study
    Roslind, Anne
    Johansen, Julia S.
    Junker, Nanna
    Nielsen, Dorte L.
    Dzaferi, Hanife
    Price, Paul A.
    Balslev, Eva
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (04): : 371 - 381
  • [32] DNA fingerprinting of benign and malignant breast lesions
    Sibbering, M
    ORourke, S
    Stanley, J
    Gilmour, A
    Reid, A
    Parkin, D
    Ellis, I
    Elston, C
    Blamey, R
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (06): : 574 - 577
  • [33] BENIGN AND MALIGNANT LESIONS OF THE BREAST IN POSTMENOPAUSAL WOMEN
    DAO, TL
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1964, 7 (02): : 603 - 620
  • [34] Benign and malignant spindle cell lesions of the breast
    Brogi, E
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2004, 21 (01) : 57 - 64
  • [36] Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions
    Eman Taha Ali
    Mai Abdulrahman Mohammed Masri
    Emmanuel Edwar Siddig
    Ayman Ahmed
    Mohamed S. Muneer
    Nouh Saad Mohamed
    Ali Mahmoud Mohammed Edris
    BMC Research Notes, 13
  • [37] Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions
    Ali, Eman Taha
    Masri, Mai Abdulrahman Mohammed
    Siddig, Emmanuel Edwar
    Ahmed, Ayman
    Muneer, Mohamed S.
    Mohamed, Nouh Saad
    Edris, Ali Mahmoud Mohammed
    BMC RESEARCH NOTES, 2020, 13 (01)
  • [38] EXPRESSION OF TISSUE PLASMINOGEN-ACTIVATOR (TPA) IN BENIGN AND MALIGNANT BREAST-LESIONS
    COOKE, DAP
    RIISNAES, R
    HAINES, A
    MAHMOUD, M
    GAFFNEY, PJ
    BURNAN, KG
    HEYDERMAN, E
    JOURNAL OF PATHOLOGY, 1988, 154 (01): : A45 - A45
  • [39] EXPRESSION OF A-TISSUE AND B-TISSUE ISOANTIGENS IN BENIGN AND MALIGNANT LESIONS OF THE BREAST
    STRAUCHEN, JA
    BERGMAN, SM
    HANSON, TAS
    CANCER, 1980, 45 (08) : 2149 - 2155
  • [40] IMMUNOHISTOCHEMICAL EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN BENIGN AND MALIGNANT LESIONS OF THE BREAST
    WADA, T
    YASUTOMI, M
    YAMADA, K
    KUNIKATA, M
    HIGASHIYAMA, H
    SHRESTHA, P
    MORI, M
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1991, 24 (05) : 449 - 455